MSF Field Research > 1 Published Research and Commentary > Vaccination > The case for reactive mass oral cholera vaccinations

Please use this identifier to cite or link to this item:     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!

Download this article:
View/Open File Description Size Format
110125_Reyburn_The-Case-for-Reactive-Mass-Oral-Cholera-Vaccinations_PLoS-Negl-Trop-Dis-5-1-e952.pdfMain Article1708KbAdobe PDF

Title: The case for reactive mass oral cholera vaccinations
Authors: Reyburn, Rita
Deen, Jacqueline L
Grais, Rebecca F
Bhattacharya, Sujit K
Sur, Dipika
Lopez, Anna L
Jiddawi, Mohamed S
Clemens, John D
von Seidlein, Lorenz
Affiliation: International Vaccine Institute (IVI), Seoul, Korea; Epicentre, Paris, France; NICED, Kolkata, India; Ministry of Health and Social Welfare, Zanzibar, Tanzania; Menzies School of Health Research, Casuarina, Australia
Citation: PLoS Negl Trop Dis 2011;5(1):e952
Journal: PLoS Neglected Tropical Diseases
Issue Date: 25-Jan-2011
DOI: 10.1371/journal.pntd.0000952
PubMed ID: 21283614
Additional Links:
Abstract: The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.
Type: Article
Language: en
MeSH: Adolescent
Aged, 80 and over
Child, Preschool
Cholera Vaccines
Computer Simulation
Disease Outbreaks
Infant, Newborn
Mass Vaccination
Middle Aged
Models, Statistical
Young Adult
ISSN: 1935-2735
Rights: Archived with thanks to PLoS Neglected Tropical Diseases and its Open Access policy.
Appears in topics: Vaccination

Related articles on PubMed
Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, Bhattachan A, You YA, Puri MK, Lopez AL, Maskery B, Nair GB, Clemens JD, Wierzba TF
2014 Feb
Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.
Schaetti C, Hutubessy R, Ali SM, Pach A, Weiss MG, Chaignat CL, Khatib AM
2009 Apr 7
Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbens RJ, Hutubessy R
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J
2012 Nov
First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Dialo AA, Itama C, Serafini M, Legros D, Grais RF
See all 246 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.


OR Logo Powered by Open Repository | Cookies


MSF logo MSF Field Research

Aug 29, 2015